In addition to be known as an international standard organisation, GS1 Healthcare is a recognised neutral and open community bringing together all related healthcare stakeholders to lead the successful development and implementation of global GS1 standards enhancing patient safety, operational and supply chain efficiencies.
In this context, traceability and the fight against counterfeit medicines and medical devices is at the center of many of our ongoing projects and initiatives. In 2019, GS1 held the 2nd African Healthcare Conference held in Lagos, Nigeria to share knowledge and experiences about using GS1 standards to enable traceability and access to safe medicines for patients around the world. On that occasion, under the lead of the National Agency for Food and Drug Administration and Control in Nigeria (NAFDAC), a call to action for the Africa Strategy for Pharmaceutical Traceability was signed by twenty-five African regulatory authorities and six health financing and donor organisations committing to pursue pharmaceutical traceability based on global supply chain standards.
GS1 also works closely with regulatory bodies, supporting pharmaceutical traceability and Unique Device Identification (UDI) regulations and standards in more than 70 countries globally; in 2019 GS1 was designated as an issuing entity for Unique Device Identification (UDI) by the European Commission, enabling medical device manufacturers to use GS1 standards in order to meet European UDI requirements.